Lipid metabolism and TNF-α secretion in response to dietary sterols in human monocyte derived macrophages

European Journal of Clinical Investigation

Volumn 35, Issue 8, 2005, Pages 482-490

  Napolitano, M ^a   Bravo, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cholesterol; Chylomicron remnant like particles; Cytokine; Dietary sterols; Macrophage; Oxysterols

Indexed keywords

7BETA HYDROXYCHOLESTEROL; CHYLOMICRON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; OXYSTEROL; SCAVENGER RECEPTOR; STEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ARTICLE; ATHEROGENESIS; AUTOOXIDATION; CHOLESTEROL METABOLISM; CYTOKINE RELEASE; DOSE RESPONSE; ESTERIFICATION; FAT INTAKE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERNALIZATION; LIPID METABOLISM; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL;

CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTERS; CHYLOMICRON REMNANTS; CHYLOMICRONS; DIET; HUMANS; HYDROXYCHOLESTEROLS; INTERLEUKIN-10; INTERLEUKIN-6; KETOCHOLESTEROLS; LIPID METABOLISM; LIPOPROTEINS; MACROPHAGES; MONOCYTES; POSTPRANDIAL PERIOD; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23844455236     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01523.x     Document Type: Article

References (53)

1. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181-90.
2. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:211-7.
3. Osterud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev 2003;83:1069-112.
4. Brown MS, Goldstein JL. Lipoprotein metabolism in macrophage: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983;52:223-61.
5. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K et al. The multiple roles of macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J Atheroscler Thromb 1997;4:1-11.
6. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediate uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333-7.
7. Steinbrecher UP. Receptors for oxidized low-density lipoprotein. Biochim Biophys Acta 1999;1436:279-98.
8. Mamo JCL. Atherosclerosis as a postprandial disease. Endocrinol Metab 1995;2:229-44.
9. Yu KC, Cooper AD. Postprandial lipoproteins and atherosclerosis. Front Biosci 2001;6:D332-54.
10. Yu KC, Mamo JC. Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin Sci (Lond.) 2000;98:183-92.
11. Napolitano M, Rivabene R, Avella M, Botham KM, Bravo E. The internal redox balance of the cells influences the metabolism of lipids of dietary origin by J774 macrophages: implication for foam cell formation. J Vasc Res 2001;38:350-60.
12. Napolitano M, Avella M, Botham KM, Bravo E. Chylomicron remnant induction of lipid accumulation in J774 macrophages is associated with up-regulation of triacylglycerol synthesis, which is not dependent on oxidation of the particles. Biochi Biophys Acta 2003;1631:255-64.
13. Batt KV, Avella M, Moore EH, Jackson B, Suckling KE, Botham KM. Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Exp Biol Med 2004;229:528-37.
14. Moore EH, Napolitano M, Avella M, Bejta F, Suckling KE, Bravo E et al. Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells. Eur J Biochem 2004;271:2417-27.
15. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1-28.
16. Schroepfer GJ Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000;80:361-554.
17. Rimner A, Al Makdessi S, Sweidan H, Wischhusen J, Rabenstein B, Shatat K, et al. Relevance and mechanism of oxysterol stereospecifity in coronary artery disease. Free Radic Biol Med 2005;38:535-44.
18. Brown A, Leong SL, Dean RT, Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low-density lipoprotein and human atherosclerotic plaque. J Lipid Res 1997;38:1730-45.
19. Vine DF, Croft KD, Beilin LJ, Mamo JC. Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons. Lipids 1997;32:887-93.
20. Lyons MA, Brown A. Metabolism of an oxysterol, 7-ketocholesterol, by sterol 27-hydroxylase in HepG2 cells. Lipids 2001;36:701-11.
21. Lyons MA, Maeda N, Brown AJ. Paradoxical enhancement of hepatic metabolism of 7-ketocholesterol in sterol 27-hydroxylase-deficient mice. Biochim Biophys Acta 2002;1581:119-26.
22. Lyons MA, Brown AJ. 7-Ketocholesterol delivered to mice in chylomicron remnant-like particles is rapidly metabolised, excreted and does not accumulate in aorta. Biochim Biophys Acta 2001;1530:209-18.
23. Vine DF, Mamo JC, Beilin LJ, Mori TA, Croft KD. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits. J Lipid Res 1998;39:1995-2004.
24. Vine DF, Croft KD, Beilin LJ, Mamo JC. Effect of dietary cholesterol oxidation products on the plasma clearance of chylomicrons in the rat. Lipids 2002;37:455-62.
25. Bravo E, Napolitano M, Rivabene R. Role of pre-existing profile of human macrophages on lipid synthesis and cholesteryl ester cycle in presence of native, acetylated and oxidised LDL. J Steroid Biochem Med Biol 2001;77:73-81.
26. Diard P, Malewiak MI, Lagrange D, Griglio S. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem J 1994;299:889-94.
27. Napolitano M, Batt KV, Avella M, Bravo E, Botham KM. Lipid synthesis in macrophages derived from the human cell line THP-1: modulation of the effects of native and oxidized chylomicron remnant-like particles by oestrogen. Clin Sci (Lond.) 2001;101:403-13.
28. Jackson KG, Robertson MD, Fielding BA, Frayn KN, Williams CM. Measurement of apolipoprotein B-48 in the Svedberg flotation rate (S(f)) > 400, S(f) 60-400 and S(f) 20-60 lipoprotein fractions reveals novel findings with respect to the effects of dietary fatty acids on triacylglycerol-rich lipoproteins in postmenopausal women. Clin Sci (Lond) 2002;103:227-37.
29. Davis RA, Engelhorn SC, Pangburn SH, Weinstein DB, Steinberg D. Very low-density lipoprotein synthesis and secretion by cultured rat hepatocytes. J Biol Chem 1979;254:2010-6.
30. Napolitano M, Bravo E. Activation of protein kinase C by phorbol esters in human macrophages reduces the metabolism of modified LDL by down-regulation of scavenger receptor activity. Int J Biochem Cell Biol 2003;35:1127-43.
31. Bradford M. A sensitive method for quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal Biochem 1976;72:248-54.
32. Armitage P, Berry G. Statistical Methods in Med Research, 2nd edn. Oxford: Blackwell Scientific Publications; 1987.
33. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ. Elevated remnant-like particle cholesterol concentration. A characteristic feature of the atherogenic lipoprotein phenotype. Circulation 2004;109:1918-25.
34. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary heart disease. Arterioscler Thromb 1991;11:653-62.
35. Proctor SD, Mamo JC. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall - evidence that plaque cholesterol may be derived from postprandial lipoproteins. Eur J Clin Invest 1998;28:497-503.
36. van de Bovenkamp P, Kosmeijer-Schuil TG, Katan MB. Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids 1988;23:1079-85.
37. Clare K, Hardwick SJ, Carpenter KL, Weeratunge N, Mitchinson MJ. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 1995;118:67-75.
38. Staprans I, Pan XM, Rapp JH, Feingold KR. Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum. J Lipid Res 2003;44:705-15.
39. Fong LG, Fong TA, Cooper AD. Inhibition of mouse macrophage degradation of acetyl low-density lipoprotein by interferon-gamma. J Biol Chem 1990;265:11751-60.
40. Ares MP, Stollenwerk M, Olsson A, Kallin B, Jovinge S, Nilsson J. Decreased inducibility of TNF expression in lipid-loaded macrophages. BMC Immunol 2002;3:13-7.
41. Rosklint T, Ohlsson BG, Wiklund O, Noren K, Kulten LM. Oxysterols induce interleukin 1beta production in human macrophages. Eur J Clin Invest 2002;32:35-42.
42. von der Thusen JH, Kuiper J, van Berkel TJEA, Biessen EA. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003;55:133-66.
43. Leake DS, May G, Soyombo AA, Nasr-Esfahani MH. The effect of macrophage stimulation on the uptake of acetylated low-density lipoproteins. Biochim Biophys Acta 1989;1005:196-200.
44. van Lenten BJ, Fogelman AM, Seager J, Ribi E, Haberland ME, Edwards PA. Bacterial endotoxin selectively prevents scavenger-receptor activity on human monocyte derived macrophage. J Immunol 1985;134:3718-21.
45. Oiknine J, Aviram M. Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages. Arterioscler Thromb 1992;12:745-53.
46. Kruth HS, Huang W, Ishii I, Zhang WY, Sonobe M. Macrophage foam cell formation with native low-density lipoprotein. J Biol Chem 2002;277:34573-80.
47. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, et al Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005;180:11-7.
48. Hsu HY, Nicholson AC, Hajjar DP. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J Biol Chem 1996;271:7767-73.
49. Geng YJ, Hansson GK. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992;89:1322-30.
50. Liao HS, Matsumoto A, Itakura H, Doi T, Honda M, Kodoma T et al. Transcriptional inhibition by interleukin-6 of the class A macrophage scavenger receptor in macrophages derived from peripheral monocytes and the THP-1 monocytic cell line. Arterioscler Thromb Vasc Biol 1999;19:1872-80.
51. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996;335:848-54.
52. Wajchenberg BL, Amancio RF, Santomauro AT, Maranhao RC. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons. Clin Endocrinol, 2004;61:347-52.
53. Martins IJ, Redgrave TG. Obesity and postprandial lipid metabolism. Feast or famine? J Nutr Biochem 2004;15:130-41.